GURUFOCUS.COM » STOCK LIST » Basic Materials » Metals & Mining » Pantera Minerals Ltd (ASX:PFE) » Definitions » ROCE %

Pantera Minerals (ASX:PFE) ROCE % : -14.23% (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Pantera Minerals ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Pantera Minerals's annualized ROCE % for the quarter that ended in Dec. 2023 was -14.23%.


Pantera Minerals ROCE % Historical Data

The historical data trend for Pantera Minerals's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pantera Minerals ROCE % Chart

Pantera Minerals Annual Data
Trend Jun22 Jun23
ROCE %
-24.72 -24.66

Pantera Minerals Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23
ROCE % -21.63 -30.36 -18.11 -30.97 -14.23

Pantera Minerals ROCE % Calculation

Pantera Minerals's annualized ROCE % for the fiscal year that ended in Jun. 2023 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Jun. 2023 )  (A: Jun. 2022 )(A: Jun. 2023 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Jun. 2023 )  (A: Jun. 2022 )(A: Jun. 2023 )
=-1.88/( ( (8.859 - 0.453) + (7.121 - 0.28) )/ 2 )
=-1.88/( (8.406+6.841)/ 2 )
=-1.88/7.6235
=-24.66 %

Pantera Minerals's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2023 )  (Q: Jun. 2023 )(Q: Dec. 2023 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2023 )  (Q: Jun. 2023 )(Q: Dec. 2023 )
=-1.118/( ( (7.121 - 0.28) + (9.344 - 0.474) )/ 2 )
=-1.118/( ( 6.841 + 8.87 )/ 2 )
=-1.118/7.8555
=-14.23 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2023) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pantera Minerals  (ASX:PFE) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.


Pantera Minerals ROCE % Related Terms

Thank you for viewing the detailed overview of Pantera Minerals's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Pantera Minerals (ASX:PFE) Business Description

Traded in Other Exchanges
N/A
Address
10 Outram Street,, Level 2, West Perth, Perth, WA, AUS, 6005
Pantera Minerals Ltd is a mineral exploration company. Its projects include the Superbird Lithium Brine project, Hellcat Lead-Silver project, Yampi Iron Ore and Copper projects, Fredrick Pollymetalic projects, and the Weelarrana Manganese project. It operates in the given segment which is mineral exploration and evaluation in Western Australia.

Pantera Minerals (ASX:PFE) Headlines

From GuruFocus

Pfizer Inc to Review Oral GLP-1 Data Call Transcript

By GuruFocus Research 01-23-2024

Pfizer Inc at Citi BioPharma Conference Transcript

By GuruFocus Research 01-23-2024

Pfizer Inc To Host Investment Analysts Call Transcript

By GuruFocus Research 01-23-2024

Pfizer Inc's Dividend Analysis

By GuruFocus Research 01-24-2024

Q3 2022 Pfizer Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024

Pfizer Inc at Wells Fargo Healthcare Conference Transcript

By GuruFocus Research 01-23-2024

Pfizer Inc at JPMorgan Healthcare Conference Transcript

By GuruFocus Research 01-23-2024